Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genentech, Inc.
Canadian Cancer Trials Group
Hanmi Pharmaceutical Company Limited
OHSU Knight Cancer Institute
American Society of Clinical Oncology
City of Hope Medical Center
Cancer Research UK
Cancer Research UK
Baylor College of Medicine
Rigshospitalet, Denmark
Helsinki University Central Hospital